Publication Name	World Journal of Nephrology
Manuscript ID	100117
Country	India

Category	Urology & Nephrology
Manuscript Type	Clinical Trials Study
Article Title	Sucroferric oxyhydroxide monotherapy for hyperphosphatemia in Indian chronic kidney disease patients undergoing hemodialysis: A phase IV, single-arm, open-label study
Manuscript Source	Unsolicited Manuscript
All Author List	M R Niranjan, Sanjay Srinivasa, Vibhanshu Gupta, Anil K Bhalla, Ankush Gaikwad, Prajakta Wangikar, Sachin Suryawanshi and Priti Gajbe
Funding Agency and Grant Number
Corresponding Author	Sanjay Srinivasa, MD, Department of Nephrology, Dr. Sanjay’s Center for Kidney and Diabetes, 357/B, Bangalore Bellary Road, Near to HDFC Bank, Yelahanka Town, Opposite RR Gold Palace, Bengaluru 560064, Karnātaka, India. drsanjay.nephro@gmail.com
Key Words	Sucroferric oxyhydroxide; Iron-based phosphate binder; Hyperphosphatemia; Hemodialysis; Dynulta™; Chronic kidney disease
Core Tip	This is the first research study on the use of Sucroferric oxyhydroxide (SO) in Indian patients and also marks the first such study from the Southeast Asia region. The study was a single-arm study, registered with the Clinical Trials Registry India. The positive results from this study will add to the growing body of evidence, primarily generated in the United States and European Union, supporting the efficacy of SO in the Asian population.
Citation	<p>Niranjan MR, Srinivasa S, Gupta V, Bhalla AK, Gaikwad A, Wangikar P, Suryawanshi S, Gajbe P. Sucroferric oxyhydroxide monotherapy for hyperphosphatemia in Indian chronic kidney disease patients undergoing hemodialysis: A phase IV, single-arm, open-label study. <i>World J Nephrol</i> 2025; 14(2): 100117</p>

Received	2024-09-27 08:20
Peer-Review Started	2024-08-08 12:02
To Make the First Decision
Return for Revision	2024-11-18 09:09
Revised	2024-12-02 04:51
Second Decision	2025-02-05 02:45
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-02-06 08:40
Articles in Press	2025-02-06 08:40
Publication Fee Transferred	2024-12-31 06:51
Edit the Manuscript by Language Editor
Typeset the Manuscript	2025-02-24 01:15

ISSN	2220-6124 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com